I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst David Bailey maintained a Sell rating on Ramsay Health Care (RMSYF) with a price target of A$41.90, down from the stock's recent close of A$51.80. This contrasts with the broader analyst consensus, which rates the stock as a Hold with an average price target of A$50.56.
In a report released on September 3, David Bailey from Morgan Stanley maintained a Sell rating on Ramsay Health Care, with a price target of A$41.90. The company’s shares closed last Friday at A$51.80.
Bailey covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, CSL, and Integral Diagnostics Ltd.. According to TipRanks, Bailey has an average return of 8.9% and a 50.86% success rate on recommended stocks.
Ramsay Health Care has an analyst consensus of Hold, with a price target consensus of A$50.56.